nile Antibody
nile Antibody
Nile Red |
|||
B8209-50 | ApexBio | 50 mg | 125 EUR |
Nile Red |
|||
B8209-500 | ApexBio | 500 mg | 212 EUR |
Nile Red |
|||
GT2331-1G | Glentham Life Sciences | 1 g | 174 EUR |
Nile Red |
|||
GT2331-250MG | Glentham Life Sciences | 250 mg | 87 EUR |
West Nile virus antibody |
|||
10-1436 | Fitzgerald | 100 ug | 408 EUR |
Description: Mouse monoclonal West Nile virus antibody |
|||
West Nile virus antibody |
|||
10-1437 | Fitzgerald | 100 ug | 408 EUR |
Description: Mouse monoclonal West Nile virus antibody |
|||
West Nile Virus (WNV) Antibody |
|||
abx412023-01mg | Abbexa | 0.1 mg | 509 EUR |
West Nile Virus Matrix Antibody |
|||
24278-100ul | SAB | 100ul | 390 EUR |
West Nile Virus Matrix Antibody |
|||
24279-100ul | SAB | 100ul | 390 EUR |
West Nile Virus Core Antibody |
|||
24281-100ul | SAB | 100ul | 390 EUR |
West Nile Virus Envelope Antibody |
|||
24282-100ul | SAB | 100ul | 390 EUR |
West Nile Virus Envelope Antibody |
|||
24283-100ul | SAB | 100ul | 390 EUR |
West Nile Virus Envelope Antibody |
|||
24284-100ul | SAB | 100ul | 390 EUR |
West Nile Virus Matrix Antibody |
|||
3429-002mg | ProSci | 0.02 mg | 171.82 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
3429-01mg | ProSci | 0.1 mg | 436.42 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
3431-002mg | ProSci | 0.02 mg | 171.82 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
3431-01mg | ProSci | 0.1 mg | 436.42 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Core Antibody |
|||
3435-002mg | ProSci | 0.02 mg | 171.82 EUR |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
|||
West Nile Virus Core Antibody |
|||
3435-01mg | ProSci | 0.1 mg | 436.42 EUR |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
|||
West Nile Virus Envelope Antibody |
|||
3437-002mg | ProSci | 0.02 mg | 171.82 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3437-01mg | ProSci | 0.1 mg | 436.42 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3439-002mg | ProSci | 0.02 mg | 171.82 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3439-01mg | ProSci | 0.1 mg | 436.42 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3441-002mg | ProSci | 0.02 mg | 171.82 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3441-01mg | ProSci | 0.1 mg | 436.42 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Protein Antibody |
|||
abx022312-1mg | Abbexa | 1 mg | 1080 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022314-1mg | Abbexa | 1 mg | 1024 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022315-1mg | Abbexa | 1 mg | 1080 EUR |
West Nile Virus Envelope Protein Antibody |
|||
abx022316-1mg | Abbexa | 1 mg | 1080 EUR |
West Nile Virus Core Protein Antibody |
|||
abx023202-100ug | Abbexa | 100 ug | 676 EUR |
Polyclonal West Nile Virus Envelope Antibody |
|||
APR11226G | Leading Biology | 0.1 mg | 659 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal West Nile Virus Matrix Antibody |
|||
APR11227G | Leading Biology | 0.1 mg | 659 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Matrix . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal West Nile Virus Core Antibody |
|||
AMM05447G | Leading Biology | 0.1 mg | 659 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Core . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal West Nile Virus Envelope Antibody |
|||
AMM05448G | Leading Biology | 0.1 mg | 659 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal West Nile Virus Envelope Antibody |
|||
AMM05449G | Leading Biology | 0.1 mg | 659 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal West Nile Virus Matrix Antibody |
|||
AMM05450G | Leading Biology | 0.1 mg | 659 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Matrix . This antibody is tested and proven to work in the following applications: |
|||
Nile Blue A (sulfate) |
|||
HY-101900 | MedChemExpress | 10mM/1mL | 126 EUR |
Mouse antibody for West Nile Virus Envelope |
|||
3631 | Virostat | 100 ug | 321.88 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
Mouse antibody for West Nile Virus Envelope |
|||
3641 | Virostat | 100 ug | 321.88 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
Mouse antibody for West Nile Virus Envelope |
|||
3655 | Virostat | 100 ug | 321.88 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
Mouse antibody for West Nile Virus Envelope |
|||
3661 | Virostat | 100 ug | 321.88 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
Mouse antibody for West Nile Virus Envelope |
|||
3671 | Virostat | 100 ug | 321.88 EUR |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
|||
Native West Nile Virus antigen |
|||
DAGA-3052 | Creative Diagnostics | 1mg | 1066 EUR |
Native West Nile Virus antigen |
|||
DAGA-3053 | Creative Diagnostics | 1mg | 1066 EUR |
West nile virus PCR kit |
|||
PCR-VH054-48R | Bioingentech | 50T | 823 EUR |
West nile virus PCR kit |
|||
PCR-VH054-96R | Bioingentech | 100T | 1113 EUR |
Recombinant West Nile Envelope Virus |
|||
7-07960 | CHI Scientific | 100µg | Ask for price |
Recombinant West Nile Envelope Virus |
|||
7-07961 | CHI Scientific | 500µg | Ask for price |
Recombinant West Nile Envelope Virus |
|||
7-07962 | CHI Scientific | 1000µg | Ask for price |
West Nile Virus Envelope Protein |
|||
abx060680-100ug | Abbexa | 100 ug | 662 EUR |
West Nile Envelope Virus Protein |
|||
20-abx260322 | Abbexa |
|
|
Nile Blue A (C.I. 51180) |
|||
GT3036-25G | Glentham Life Sciences | 25 g | 86 EUR |
West Nile virus protein (Horse) |
|||
30-1261 | Fitzgerald | 250 ug | 457 EUR |
Description: Purified recombinant West Nile virus protein (Horse) |
|||
West Nile Virus NS1 protein |
|||
80-1546 | Fitzgerald | 100 ug | 451 EUR |
Description: Purified Recombinant West Nile Virus NS1 protein (His tag) |
|||
West Nile Virus Matrix Peptide |
|||
3429P | ProSci | 0.05 mg | 164.75 EUR |
Description: (IN) West Nile Virus Matrix peptide |
|||
West Nile Virus Matrix Peptide |
|||
3431P | ProSci | 0.05 mg | 164.75 EUR |
Description: (CT) West Nile Virus Matrix peptide |
|||
West Nile Virus Core Peptide |
|||
3435P | ProSci | 0.05 mg | 164.75 EUR |
Description: (CT) West Nile Virus Core peptide |
|||
West Nile Virus Envelope Peptide |
|||
3437P | ProSci | 0.05 mg | 164.75 EUR |
Description: (IN) West Nile Virus Envelope peptide |
|||
West Nile Virus Envelope Peptide |
|||
3439P | ProSci | 0.05 mg | 164.75 EUR |
Description: (NT) West Nile Virus Envelope peptide |
|||
West Nile Virus Envelope Peptide |
|||
3441P | ProSci | 0.05 mg | 164.75 EUR |
Description: (IN) West Nile Virus Envelope peptide |
|||
Recombinant West Nile Pre-M Virus |
|||
7-07963 | CHI Scientific | 100µg | Ask for price |
Recombinant West Nile Pre-M Virus |
|||
7-07964 | CHI Scientific | 500µg | Ask for price |
Recombinant West Nile Pre-M Virus |
|||
7-07965 | CHI Scientific | 1000µg | Ask for price |
West Nile Virus Envelope recombinant antigen |
|||
8822 | Virostat | 100 ug | 441.5 EUR |
Description: This is West Nile Virus Envelope recombinant antigen for ELISA,WB. |
|||
West Nile Virus Pre-M Protein |
|||
abx060681-100ug | Abbexa | 100 ug | 662 EUR |
West Nile Pre-M Virus Protein |
|||
20-abx260323 | Abbexa |
|
|
West Nile Virus Envelope recombinant antigen |
|||
00401-V-01mg | Virogen | 0,1 mg | 267.5 EUR |
Description: West Nile Virus Envelope recombinant antigen-Immunodominant region |
|||
West Nile Virus Envelope recombinant antigen |
|||
00401-V-1000ug | Virogen | 1000 ug | 1282.5 EUR |
Description: West Nile Virus Envelope recombinant antigen-Immunodominant region |
|||
West Nile Virus ENV recombinant antigen |
|||
00403-V-01mg | Virogen | 0,1 mg | 267.5 EUR |
Description: West Nile Virus Envelope full length recombinant antigen 42 kDa region |
|||
West Nile Virus ENV recombinant antigen |
|||
00403-V-1000ug | Virogen | 1000 ug | 1282.5 EUR |
Description: West Nile Virus Envelope full length recombinant antigen 42 kDa region |